The Impact of MicroRNA-133a on Prognosis and Clinicopathological Parameters for Digestive System Cancers: a Comprehensive Study Based on Meta-Analysis and TCGA Database
Tóm tắt
Từ khóa
Tài liệu tham khảo
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108. https://doi.org/10.3322/caac.21262
Pourhoseingholi MA, Vahedi M, Baghestani AR (2015) Burden of gastrointestinal cancer in Asia; an overview. Gastroenterol Hepatol Bed Bench 8(1):19–27
Yuequan J, Shifeng C, Bing Z (2010) Prognostic factors and family history for survival of esophageal squamous cell carcinoma patients after surgery. Ann Thorac Surg 90(3):908–913. https://doi.org/10.1016/j.athoracsur.2010.05.060
Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, Lin C, Socci ND, Hermida L, Fulci V, Chiaretti S, Foa R, Schliwka J, Fuchs U, Novosel A, Muller RU, Schermer B, Bissels U, Inman J, Phan Q, Chien M, Weir DB, Choksi R, De Vita G, Frezzetti D, Trompeter HI, Hornung V, Teng G, Hartmann G, Palkovits M, Di Lauro R, Wernet P, Macino G, Rogler CE, Nagle JW, Ju J, Papavasiliou FN, Benzing T, Lichter P, Tam W, Brownstein MJ, Bosio A, Borkhardt A, Russo JJ, Sander C, Zavolan M, Tuschl T (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129(7):1401–1414. https://doi.org/10.1016/j.cell.2007.04.040
Gao SH, Liu J, Zhang HJ, Zhao N, Zhang J (2016) Low miR-133a expression is a predictor of outcome in patients with esophageal squamous cell cancer. Eur Rev Med Pharmacol Sci 20(18):3788–3792
Li CY, Liang GY, Yao WZ, Sui J, Shen X, Zhang YQ, Peng H, Hong WW, Ye YC, Zhang ZY, Zhang WH, Yin LH, Pu YP (2017) Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression. Clin Transl Oncol 19(2):162–172. https://doi.org/10.1007/s12094-016-1516-y
Wan TM, Lam CS, Ng L, Chow AK, Wong SK, Li HS, Man JH, Lo OS, Foo D, Cheung A, Yau T, Poon JT, Poon RT, Law WL, Pang RW (2014) The clinicopathological significance of miR-133a in colorectal cancer. Dis Markers 2014:919283–919288. https://doi.org/10.1155/2014/919283
Qin Y, Dang X, Li W, Ma Q (2013) miR-133a functions as a tumor suppressor and directly targets FSCN1 in pancreatic cancer. Oncol Res 21(6):353–363. https://doi.org/10.3727/096504014x14024160459122
Krieg A, Riemer JC, Telan LA, Gabbert HE, Knoefel WT (2015) CXCR4--a prognostic and Clinicopathological biomarker for pancreatic ductal adenocarcinoma: a meta-analysis. PLoS One 10(6):e0130192. https://doi.org/10.1371/journal.pone.0130192
Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605. https://doi.org/10.1007/s10654-010-9491-z
Riley RD, Elia EG, Malin G, Hemming K, Price MP (2015) Multivariate meta-analysis of prognostic factor studies with multiple cut-points and/or methods of measurement. Stat Med 34(17):2481–2496. https://doi.org/10.1002/sim.6493
Suzuki S, Yokobori T, Tanaka N, Sakai M, Sano A, Inose T, Sohda M, Nakajima M, Miyazaki T, Kato H, Kuwano H (2012) CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma. Oncol Rep 28(2):465–472. https://doi.org/10.3892/or.2012.1831
Akanuma N, Hoshino I, Akutsu Y, Murakami K, Isozaki Y, Maruyama T, Yusup G, Qin W, Toyozumi T, Takahashi M, Suito H, Hu X, Sekino N, Matsubara H (2014) MicroRNA-133a regulates the mRNAs of two invadopodia-related proteins, FSCN1 and MMP14, in esophageal cancer. Br J Cancer 110(1):189–198. https://doi.org/10.1038/bjc.2013.676
Chen G, Peng J, Zhu W, Tao G, Song Y, Zhou X, Wang W (2014) Combined downregulation of microRNA-133a and microRNA-133b predicts chemosensitivity of patients with esophageal squamous cell carcinoma undergoing paclitaxel-based chemotherapy. Med Oncol 31(11):263. https://doi.org/10.1007/s12032-014-0263-6
Cheng Z, Liu F, Wang G, Li Y, Zhang H, Li F (2014) miR-133 is a key negative regulator of CDC42-PAK pathway in gastric cancer. Cell Signal 26(12):2667–2673. https://doi.org/10.1016/j.cellsig.2014.08.012
Wang LL, Du LT, Li J, Liu YM, Qu AL, Yang YM, Zhang X, Zheng GX, Wang CX (2014) Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients. World J Gastroenterol 20(32):11340–11346. https://doi.org/10.3748/wjg.v20.i32.11340
Zhang W, Liu K, Liu S, Ji B, Wang Y, Liu Y (2015) MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma. Tumour Biol 36(12):9779–9788. https://doi.org/10.1007/s13277-015-3749-8
Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6(11):857–866. https://doi.org/10.1038/nrc1997
Kaluzna EM (2014) MicroRNA-155 and microRNA-196b: promising biomarkers in hepatitis C virus infection? Rev Med Virol 24(3):169–185. https://doi.org/10.1002/rmv.1785
Han ZB, Chen HY, Fan JW, Wu JY, Tang HM, Peng ZH (2012) Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation. J Cancer Res Clin Oncol 138(1):153–161. https://doi.org/10.1007/s00432-011-1076-z
Godfrey AC, Xu Z, Weinberg CR, Getts RC, Wade PA, DeRoo LA, Sandler DP, Taylor JA (2013) Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the sister study cohort. Breast Cancer Res 15(3):R42. https://doi.org/10.1186/bcr3428
Wang LK, Hsiao TH, Hong TM, Chen HY, Kao SH, Wang WL, Yu SL, Lin CW, Yang PC (2014) MicroRNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinoma. PLoS One 9(5):e96765. https://doi.org/10.1371/journal.pone.0096765
Li S, Xiao FY, Shan PR, Su L, Chen DL, Ding JY, Wang ZQ (2015) Overexpression of microRNA-133a inhibits ischemia-reperfusion-induced cardiomyocyte apoptosis by targeting DAPK2. J Hum Genet 60(11):709–716. https://doi.org/10.1038/jhg.2015.96
Ji F, Zhang H, Wang Y, Li M, Xu W, Kang Y, Wang Z, Wang Z, Cheng P, Tong D, Li C, Tang H (2013) MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1. Bone 56(1):220–226. https://doi.org/10.1016/j.bone.2013.05.020
Fujiwara T, Katsuda T, Hagiwara K, Kosaka N, Yoshioka Y, Takahashi RU, Takeshita F, Kubota D, Kondo T, Ichikawa H, Yoshida A, Kobayashi E, Kawai A, Ozaki T, Ochiya T (2014) Clinical relevance and therapeutic significance of microRNA-133a expression profiles and functions in malignant osteosarcoma-initiating cells. Stem Cells 32(4):959–973. https://doi.org/10.1002/stem.1618
Nohata N, Hanazawa T, Kikkawa N, Mutallip M, Fujimura L, Yoshino H, Kawakami K, Chiyomaru T, Enokida H, Nakagawa M, Okamoto Y, Seki N (2011) Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma. Int J Oncol 38(1):209–217
Zhao L, Wang H, Liu C, Liu Y, Wang X, Wang S, Sun X, Li J, Deng Y, Jiang Y, Ding Y (2010) Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1. Gut 59(9):1226–1235. https://doi.org/10.1136/gut.2009.202739
Chiyomaru T, Enokida H, Tatarano S, Kawahara K, Uchida Y, Nishiyama K, Fujimura L, Kikkawa N, Seki N, Nakagawa M (2010) miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 102(5):883–891. https://doi.org/10.1038/sj.bjc.6605570
Xiao J, Zou Y, Lu X, Xie B, Yu Q, He B, He B, Chen Q (2016) Prognostic value of decreased microRNA-133a in solid cancers: a meta-analysis. OncoTargets Ther 9:5771–5779. https://doi.org/10.2147/ott.s112358
Zhao Y, Huang J, Zhang L, Qu Y, Li J, Yu B, Yan M, Yu Y, Liu B, Zhu Z (2014) MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells. BMC Cancer 14:34. https://doi.org/10.1186/1471-2407-14-34
Li X, Wan X, Chen H, Yang S, Liu Y, Mo W, Meng D, Du W, Huang Y, Wu H, Wang J, Li T, Li Y (2014) Identification of miR-133b and RB1CC1 as independent predictors for biochemical recurrence and potential therapeutic targets for prostate cancer. Clin Cancer Res 20(9):2312–2325. https://doi.org/10.1158/1078-0432.ccr-13-1588
Chen XN, Wang KF, Xu ZQ, Li SJ, Liu Q, Fu DH, Wang X, Wu B (2014) MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1. Cancer Cell Int 14:70. https://doi.org/10.1186/s12935-014-0070-3
Qiu T, Zhou X, Wang J, Du Y, Xu J, Huang Z, Zhu W, Shu Y, Liu P (2014) MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer. FEBS Lett 588(7):1168–1177. https://doi.org/10.1016/j.febslet.2014.02.054
Kano M, Seki N, Kikkawa N, Fujimura L, Hoshino I, Akutsu Y, Chiyomaru T, Enokida H, Nakagawa M, Matsubara H (2010) miR-145, miR-133a and miR-133b: tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 127(12):2804–2814. https://doi.org/10.1002/ijc.25284